P. Gineste

Biography

Paul brings 20 years of experience in clinical development and strategy with leading international pharmaceutical and biotech companies. Paul began his career in 1998 with Boehringer Ingelheim as International Clinical Trials Manager before taking over, in 2003, the position of Head of Clinical R&D at Altana Pharma. In 2007, Paul was appointed Director of Clinical Studies at AB Science where he led the early clinical development of a tyrosine kinase inhibitor in the U.S. and Europe. In 2013, he moved to Theravectys, a spin-off of the Institut Pasteur specialized in lentiviral vectors, as Executive VP, Clinical Development. Paul joined ABIVAX in 2015 as Head of Clinical Operations. Paul holds a doctorate in pharmacy from the University of Rouen, France and a Master’s degree in Law from the University of Paris XI. Paul brings 20 years of experience in clinical development and strategy with leading international pharmaceutical and biotech companies. Paul began his career in 1998 with Boehringer Ingelheim as International Clinical Trials Manager before taking over, in 2003, the position of Head of Clinical R&D at Altana Pharma. In 2007, Paul was appointed Director of Clinical Studies at AB Science where he led the early clinical development of a tyrosine kinase inhibitor in the U.S. and Europe. In 2013, he moved to Theravectys, a spin-off of the Institut Pasteur specialized in lentiviral vectors, as Executive VP, Clinical Development. Paul joined ABIVAX in 2015 as Head of Clinical Operations. Paul holds a doctorate in pharmacy from the University of Rouen, France and a Master’s degree in Law from the University of Paris XI.

Research Interest

clinical development, medical